Send to

Choose Destination
See comment in PubMed Commons below
J Nat Prod. 1996 Feb;59(2):196-9.

Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri.

Author information

  • 1Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492, USA.


During the screening of natural products for their ability to inhibit the binding of HIV-REV protein to [33P]-labeled RRE RNA, one novel compound, niruriside (1), was isolated from the MeOH extract of the dried leaf of Phyllanthus niruri L. by bioassay-guided fractionation. The structure of niruriside was determined by spectroscopic methods. Niruriside showed specific inhibitory activity against the binding of REV protein to RRE RNA with an IC50 value of 3.3 microM; however, niruriside did not protect CEM-SS cells from acute HIV infection at concentrations up to 260 microM using an XTT dye reduction assay.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Write to the Help Desk